Ligand Pharmaceuticals IncorporatedLGNDNASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P86
Within normal range
vs 2Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
2025308.79%
2024-289.30%
2023293.22%
2022-97.08%
2021176.94%
2020-95.35%
2019392.94%
2018140.51%
201755.12%
201660.58%